Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

25.03.2024

5 AIDS
2 AIDS Res Hum Retroviruses
1 Am J Med
7 Clin Infect Dis
4 HIV Med
1 J Acquir Immune Defic Syndr
1 J Clin Oncol
1 J Infect Dis
2 J Med Virol
1 J Pediatr
2 J Virol
1 JAMA
1 Lancet
1 Lancet Infect Dis
1 Lancet Neurol
1 MMWR Morb Mortal Wkly Rep
1 Neurol Clin Pract
3 PLoS Med
4 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A



    AIDS

  1. KEMP CG, Pence BW, Velloza J, Concepcion T, et al
    Cumulative exposure to depressive symptoms and all-cause mortality among adults living with HIV in Kenya, Nigeria, Tanzania, and Uganda.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003891.
    >> Share

  2. MIGISHA R, Chen G, Muyindike WR, Aung TN, et al
    Regional variation in weight change after the transition to dolutegravir: a prospective cohort study in Uganda and South Africa.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003888.
    >> Share

  3. HAW NJL, Lesko CR, Ng DK, Lam J, et al
    Incidence of non-AIDS defining comorbidities among young adults with perinatally-acquired HIV in North America, 2000-2019.
    AIDS. 2024 Mar 19. doi: 10.1097/QAD.0000000000003892.
    >> Share

  4. CHOLLI PA, Buchacz KM, Harris NS, Crim SM, et al
    Self-rated Health and HIV Outcomes Among Adults with Diagnosed HIV - Medical Monitoring Project, United States, 2020-21.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003890.
    >> Share

  5. HU FH, Tang XL, Ge MW, Jia YJ, et al
    Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis.
    AIDS. 2024 Mar 18. doi: 10.1097/QAD.0000000000003886.
    >> Share


    AIDS Res Hum Retroviruses

  6. LAN C, Zhu B, Hailong Z, Yuting S, et al
    Near Full-Length Genome Characterization of two Novel Unique Recombinants (CRF01_AE/CRF07_BC) in Beijing, China.
    AIDS Res Hum Retroviruses. 2024 Mar 22. doi: 10.1089/AID.2023.0149.
    >> Share

  7. LE BRAZIDEC DL, Cormier K, Almonte A, Napoleon S, et al
    Pre-Exposure Prophylaxis Care Cascade Among Men Who Have Sex with Men Engaging in Partner Notification Services at a Sexually Transmitted Infections Clinic.
    AIDS Res Hum Retroviruses. 2024 Mar 18. doi: 10.1089/aid.2023.0097.
    >> Share


    Am J Med

  8. ALI K, Wiemer L, Ali AA, Quan A, et al
    Gastrointestinal Bleeding Related to Visceral Kaposi Sarcoma.
    Am J Med. 2024 Mar 16:S0002-9343(24)00171-2. doi: 10.1016/j.amjmed.2024.
    >> Share


    Clin Infect Dis

  9. KRISHNAN S, Chaisson RE
    US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
    Clin Infect Dis. 2024;78:514-517.
    >> Share

  10. BOODMAN C, Gupta N, Nelson CA, van Griensven J, et al
    Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
    Clin Infect Dis. 2024;78:554-561.
    >> Share

  11. KENYON C
    We should not downplay the risks that doxycycline PEP will select for AMR.
    Clin Infect Dis. 2024 Mar 19:ciae139. doi: 10.1093.
    >> Share

  12. HAZRA A, Celum C, Luetkemeyer AF, Molina JM, et al
    Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation.
    Clin Infect Dis. 2024 Mar 19:ciae152. doi: 10.1093.
    >> Share

  13. NGUYEN Q, Wooten D, Lee D, Moreno M, et al
    GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV.
    Clin Infect Dis. 2024 Mar 19:ciae151. doi: 10.1093.
    >> Share

  14. VALIN N, Lambert-Niclot S, Torres E, Meynard JL, et al
    A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine.
    Clin Infect Dis. 2024 Mar 21:ciad757. doi: 10.1093.
    >> Share

  15. VANBAELEN T, Tsoumanis A, Kenyon C
    Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
    Clin Infect Dis. 2024;78:803-805.
    >> Share


    HIV Med

  16. SOCIAS ME, Cui Z, Le Foll B, Lei J, et al
    Sexually transmitted and blood-borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: Findings from a Canadian pragmatic randomized trial.
    HIV Med. 2024 Mar 20. doi: 10.1111/hiv.13636.
    >> Share

  17. ZOU S, Chen Z, Tan Y, Tan M, et al
    Microbiomes detected by cerebrospinal fluid metagenomic next-generation sequencing among patients with and without HIV with suspected central nervous system infection.
    HIV Med. 2024 Mar 21. doi: 10.1111/hiv.13634.
    >> Share

  18. JACOBS TG, Okemo D, Ssebagereka A, Mwehonge K, et al
    Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda.
    HIV Med. 2024 Mar 18. doi: 10.1111/hiv.13635.
    >> Share

  19. DOU Y, Lu R, Su L, Lan K, et al
    Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin-based regimen: A retrospective observational case series.
    HIV Med. 2024 Mar 17. doi: 10.1111/hiv.13632.
    >> Share


    J Acquir Immune Defic Syndr

  20. ERENRICH RK, Braun RA, Torres-Mendoza DM, Stevenson OL, et al
    Effectiveness of PrEPTECH: Findings From a 180-Day Randomized Controlled Trial of a Pre-Exposure Prophylaxis Telehealth Intervention.
    J Acquir Immune Defic Syndr. 2024;95:463-469.
    >> Share


    J Clin Oncol

  21. MCGEE-AVILA JK, Suneja G, Engels EA, Rositch AF, et al
    Cancer Treatment Disparities in People With HIV in the United States, 2001-2019.
    J Clin Oncol. 2024 Mar 21:JCO2302366. doi: 10.1200/JCO.23.02366.
    >> Share


    J Infect Dis

  22. ZEEB M, Frischknecht P, Huber M, Schenkel CD, et al
    Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
    J Infect Dis. 2024 Mar 20:jiae149. doi: 10.1093.
    >> Share


    J Med Virol

  23. WANG Z
    Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile.
    J Med Virol. 2024;96:e29553.
    >> Share

  24. TRUNFIO M, Tang B, Okwuegbuna O, Iudicello JE, et al
    Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification of CSF controllers.
    J Med Virol. 2024;96:e29550.
    >> Share


    J Pediatr

  25. BARRIOS-TASCON A, Strehlau R, Patel F, Burke M, et al
    Growth Trajectories over the First Year of Life among Early-treated Infants with HIV and Infants Who Are HIV-exposed Uninfected.
    J Pediatr. 2024 Mar 18:114018. doi: 10.1016/j.jpeds.2024.114018.
    >> Share


    J Virol

  26. VON MALTITZ P, Wettstein L, Weil T, Schommers P, et al
    Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies.
    J Virol. 2024 Mar 19:e0119023. doi: 10.1128/jvi.01190.
    >> Share

  27. TWENTYMAN J, Emerman M, Ohainle M
    Capsid-dependent lentiviral restrictions.
    J Virol. 2024 Mar 18:e0030824. doi: 10.1128/jvi.00308.
    >> Share


    JAMA

  28. SHETH AN, Momplaisir F, Dumond JB
    Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
    JAMA. 2024;331:912-914.
    >> Share


    Lancet

  29. WATTS G
    Andrew Kerkhoff: award-winning TB and HIV physician-scientist.
    Lancet. 2024 Mar 15:S0140-6736(24)00539-7. doi: 10.1016/S0140-6736(24)00539.
    >> Share


    Lancet Infect Dis

  30. STUCK L, Klinkenberg E, Abdelgadir Ali N, Basheir Abukaraig EA, et al
    Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis.
    Lancet Infect Dis. 2024 Mar 12:S1473-3099(24)00011.
    >> Share


    Lancet Neurol


  31. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet Neurol. 2024;23:344-381.
    >> Share


    MMWR Morb Mortal Wkly Rep

  32. AJIBOYE AS, O'Connor S, Smith JP, Ahmedov S, et al
    Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:233-238.
    >> Share


    Neurol Clin Pract

  33. MBONDE AA, Chang J, Musubire AK, Okello S, et al
    HIV Infection and 90-Day Stroke Outcomes in Uganda: A Prospective Observational Cohort Study.
    Neurol Clin Pract. 2023;13:e200198.
    >> Share


    PLoS Med

  34. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    >> Share

  35. MOODIE Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, et al
    Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
    PLoS Med. 2024;21:e1004360.
    >> Share

  36. BRAZIER E, Tymejczyk O, Wools-Kaloustian K, Jiamsakul A, et al
    Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
    PLoS Med. 2024;21:e1004367.
    >> Share


    PLoS One

  37. TUMWEGAMIRE A, Fatch R, Emenyonu NI, Lodi S, et al
    Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
    PLoS One. 2024;19:e0300508.
    >> Share

  38. SAGNIA B, Mbakop Ghomsi F, Moudourou S, Gutierez A, et al
    Accurate and reproducible enumeration of CD4 T cell counts and Hemoglobin levels using a point of care system: Comparison with conventional laboratory based testing systems in a clinical reference laboratory in Cameroon.
    PLoS One. 2024;19:e0297790.
    >> Share

  39. JOHNSON SM, Teh JJ, Pasvol TJ, Ayres S, et al
    Hospitalisation rates for youth living with perinatally acquired HIV in England.
    PLoS One. 2024;19:e0295639.
    >> Share

  40. GANTA AG, Wabeto E, Minuta WM, Wegi C, et al
    Predictors of loss to follow up among adults on antiretroviral therapy before and after the start of treat-all strategy in public health facilities of Hawassa city, Ethiopia: A Competing risk regression.
    PLoS One. 2024;19:e0299505.
    >> Share


    PLoS Pathog

  41. LAYISH B, Goli R, Flick H, Huang SW, et al
    Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
    PLoS Pathog. 2024;20:e1011830.
    >> Share


    Proc Natl Acad Sci U S A

  42. SHICHIJO T, Yasunaga JI, Sato K, Nosaka K, et al
    Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2309925121.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016